share_log

Barclays Maintains Overweight on Elanco Animal Health, Lowers Price Target to $19

Benzinga ·  Feb 26 11:55

Barclays analyst Balaji Prasad maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and lowers the price target from $20 to $19.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 330
Write a comment